According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind ...

The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Here’s what you’ll learn when you read this story: We are generating staggering amounts of data every day. Data centers just can’t keep up with the demand. With data storage needs expected to soar in ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

The results showed that sac-TMT 5 mg/kg monotherapy every 2 weeks demonstrated promising antitumor activity in participants with heavily pretreated advanced or metastatic UC, with a manageable safety ...

Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study ...